These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4047494)

  • 1. Glutathione peroxidase activity in Parkinson's disease brain.
    Kish SJ; Morito C; Hornykiewicz O
    Neurosci Lett; 1985 Aug; 58(3):343-6. PubMed ID: 4047494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxygen toxicity protecting enzymes in Parkinson's disease. Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus.
    Marttila RJ; Lorentz H; Rinne UK
    J Neurol Sci; 1988 Sep; 86(2-3):321-31. PubMed ID: 3221244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
    Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
    Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain peroxidase and catalase in Parkinson disease.
    Ambani LM; Van Woert MH; Murphy S
    Arch Neurol; 1975 Feb; 32(2):114-8. PubMed ID: 1122174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione peroxidase, glial cells and Parkinson's disease.
    Damier P; Hirsch EC; Zhang P; Agid Y; Javoy-Agid F
    Neuroscience; 1993 Jan; 52(1):1-6. PubMed ID: 8433802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione-related enzymes in brain in Parkinson's disease.
    Sian J; Dexter DT; Lees AJ; Daniel S; Jenner P; Marsden CD
    Ann Neurol; 1994 Sep; 36(3):356-61. PubMed ID: 8080243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relatively high levels of dopamine in nucleus accumbens of levodopa treated patients with Parkinson's disease.
    Goldstein M; Lieberman A; Pearson J
    J Neural Transm; 1982; 54(1-2):129-34. PubMed ID: 6125563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamic acid decarboxylase in Parkinson's disease and epilepsy.
    McGeer PL; McGeer EG; Wada JA
    Neurology; 1971 Oct; 21(10):1000-7. PubMed ID: 5165300
    [No Abstract]   [Full Text] [Related]  

  • 9. Brain glutathione peroxidase in neurodegenerative disorders.
    Kish SJ; Morito CL; Hornykiewicz O
    Neurochem Pathol; 1986 Feb; 4(1):23-8. PubMed ID: 2940481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione peroxidase activity in surgical and autopsied human brains.
    Ansari KA; Bigelow D; Kaplan E
    Neurochem Res; 1985 May; 10(5):703-11. PubMed ID: 4010876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-glutamic acid decarboxylase in Parkinson's disease: effect of L-dopa therapy.
    Lloyd KG; Hornykiewicz O
    Nature; 1973 Jun; 243(5409):521-3. PubMed ID: 4743649
    [No Abstract]   [Full Text] [Related]  

  • 12. Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients.
    Perry TL; Yong VW
    Neurosci Lett; 1986 Jun; 67(3):269-74. PubMed ID: 3737015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in m-RNA expression for Cu,Zn-superoxide dismutase and glutathione peroxidase in the basal ganglia of MPTP-treated marmosets and patients with Parkinson's disease.
    Kunikowska G; Jenner P
    Brain Res; 2003 Apr; 968(2):206-18. PubMed ID: 12663090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of electroacupuncture intervention on levels of SOD, GSH, GSH-Px, MDA, and apoptosis of dopaminergic neurons in substantia Nigra in rats with Parkinson's disease].
    Li J; Wang LN; Xiao HL; Li X; Yang JJ
    Zhen Ci Yan Jiu; 2014 Jun; 39(3):185-91. PubMed ID: 25069193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group.
    Jenner P; Dexter DT; Sian J; Schapira AH; Marsden CD
    Ann Neurol; 1992; 32 Suppl():S82-7. PubMed ID: 1510385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease.
    Pearce RK; Owen A; Daniel S; Jenner P; Marsden CD
    J Neural Transm (Vienna); 1997; 104(6-7):661-77. PubMed ID: 9444566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalase and peroxidase in human brain.
    Ambani LM; Van Woert MH
    Trans Am Neurol Assoc; 1973; 98():7-10. PubMed ID: 4784979
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease.
    Ross BM; Mamalias N; Moszczynska A; Rajput AH; Kish SJ
    Neuroscience; 2001; 102(4):899-904. PubMed ID: 11182251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease: a disorder due to nigral glutathione deficiency?
    Perry TL; Godin DV; Hansen S
    Neurosci Lett; 1982 Dec; 33(3):305-10. PubMed ID: 7162692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione Peroxidase 4 is associated with Neuromelanin in Substantia Nigra and Dystrophic Axons in Putamen of Parkinson's brain.
    Bellinger FP; Bellinger MT; Seale LA; Takemoto AS; Raman AV; Miki T; Manning-Boğ AB; Berry MJ; White LR; Ross GW
    Mol Neurodegener; 2011 Jan; 6(1):8. PubMed ID: 21255396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.